Active Crohn's Disease Patients Show a Distinctive Expansion of Circulating Memory CD4+CD45RO+CD28null T Cells
Overview
Authors
Affiliations
In a previous study we found an expansion of circulating memory (CD45RO(+)) CD4(+) T cells in patients with Crohn's disease (CD). The aim of this work was to investigate the phenotypic and functional characteristics of this T-cell subset in CD. We analyzed in peripheral blood CD4(+)CD45RO(+) T cells from CD patients the expression of surface markers associated to immune activation, costimulation, and apoptosis. In sorted CD4(+)CD45RO(+) T cells apoptosis was quantified by fluorescent annexin V binding. Healthy subjects and patients with ulcerative colitis and acute bacterial enterocolitis served as control groups. An increased percentage of memory CD4(+)CD45RO(+) T cells lacking the expression of costimulatory receptor CD28 was detected in patients with active CD when compared to the other groups evaluated. This expanded CD4(+)CD45RO(+)CD28(null) T-cell subset expressed mostly the effector-cell marker CD57(+). Both CD28 downregulation and CD57 expression correlated to CDAI and surrogate markers of disease activity. These phenotypic changes observed on CD4(+)CD45RO(+) T cells from active CD returned to values similar to healthy controls after clinical remission. Moreover, this memory CD28(null) T-cell subset might express more intracytoplasmic TNF and IFN-gamma than their CD28(+) counterpart. Significantly lower frequencies of memory CD4(+)CD45RO(+) T cells expressing CD95 apoptosis receptor were found in patients with active CD. Moreover, sorted CD4(+)CD45RO(+)and CD4(+)CD45RO(+) CD28(null) T cells from patients with active CD exhibited a lower apoptotic rate than that found in healthy controls and inactive CD patients. According to our data, circulating T lymphocytes from active CD patients show distinctive phenotypic and functional changes, characterized by an expansion of memory CD4(+)CD45RO(+)CD28(null) T cells expressing effector-associated cell surface molecules and displaying enhanced resistance to apoptosis.
Exhausted Lag-3+ CD4+ T cells are increased in pediatric Inflammatory Bowel Disease.
Schnell A, Aicher C, Schnegelsberg P, Schwarz B, Schmidt H, Allabauer I Clin Exp Immunol. 2024; 219(1).
PMID: 39044534 PMC: 11771200. DOI: 10.1093/cei/uxae066.
The S, Schreurs R, Drewniak A, Bakx R, de Meij T, Budding A Front Immunol. 2024; 14:1258363.
PMID: 38239362 PMC: 10794624. DOI: 10.3389/fimmu.2023.1258363.
Pappa A, Muhrer J, Gast P, Subramanyam S, Ohl K, Muschaweck M Front Pediatr. 2023; 11:1123873.
PMID: 37456566 PMC: 10345343. DOI: 10.3389/fped.2023.1123873.
Unusual presentation of Crohn's disease.
Edwards K, Yearsley K BMJ Case Rep. 2021; 14(6).
PMID: 34108157 PMC: 8191605. DOI: 10.1136/bcr-2021-242703.
Introducing GATA3 as a prominent player in Crohn's disease.
Rezaei-Tavirani S, Asri N, Emamhadi M, Jahani-Sherafat S, Seyed Salehi A, Gholamrezaei Z Gastroenterol Hepatol Bed Bench. 2021; 13(Suppl1):S53-S59.
PMID: 33585004 PMC: 7881413.